Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1871-1880 of 2244 for

Edit search filters
  1. Spatial and Molecular Architecture of Tumor Environments Responsive to IO (immuno-oncology) Therapy

    Rochester, MN

  2. A Study to Evaluate Left and Right Ventricular Function in Relation to Exercise Capacity in Breast Cancer Survivors

    Jacksonville, FL

  3. The Young Women's Breast Cancer Study

    Rochester, MN

  4. Evaluating Surgical Treatment Related Differences in Patient Satisfaction and Health-related Quality of Life in Breast Cancer Survivors in the Long-term Survivorship Period

    Rochester, MN

  5. A Study to Evaluate Early Detection of SARS-CoV-2/COVID-19 in High Risk Radiation Oncology Patients

    Rochester, MN

  6. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development

    Jacksonville, FL

  7. A Comparison Study to Cross-validate the Linear Analogue Self-Assessment (LASA), Patient-Reported Outcomes Measurement Information System (PROMIS), and Patient-reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Assessing Cancer Patient Well-being

    Rochester, MN

  8. A Study to Investigate Blood-derived Circulating Tumor DNA, Circulating Tumor RNA, and Circulating Tumor miRNA in Pancreatic Cancer Patients

    Jacksonville, FL

  9. A Study to Explore MRI to Stage Bladder Cancer

    Jacksonville, FL

  10. Myeloproliferative Neoplasm Pain Management and Patient Habit Survey

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer